Literature DB >> 16643489

Interleukin-8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis.

Abbas Khadra1, Patricia Fletcher, Graz Luzzi, Robin Shattock, Phillip Hay.   

Abstract

OBJECTIVE: To investigate whether a range of cytokines were detectable in the seminal plasma and urine of men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and nonspecific urethritis (NSU), and whether cytokine levels correlated with symptom severity in CP/CPPS. PATIENTS AND METHODS: In all, 87 men participated, 33 with CP/CPPS, 31 with NSU, and 23 controls. Interleukin (IL)-1beta, IL-2, IL-6, IL-8 and IL-10 were measured in seminal plasma and first pass urine, and the results were correlated with scores for pain, urinary symptoms and quality-of-life impact using a validated symptom index, the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI).
RESULTS: Seminal plasma levels of IL-8 were higher in men with CP/CPPS and NSU than in controls (P < 0.001), and the levels correlated with NIH-CPSI symptom scores in men with CP/CPPS. There were no significant differences in urinary IL-8 levels in the three groups, and no significant differences in levels of the other cytokines in either semen or urine.
CONCLUSION: Semen IL-8 levels correlate with subjective symptoms in men with CP/CPPS. IL-8 might contribute to the pathophysiology of CP/CPPS and NSU, and elevated levels might be a useful marker of the condition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643489     DOI: 10.1111/j.1464-410X.2006.06133.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  19 in total

1.  Characterization of the seminal plasma proteome in men with prostatitis by mass spectrometry.

Authors:  Daniel Kagedan; Irene Lecker; Ihor Batruch; Christopher Smith; Ilia Kaploun; Kirk Lo; Ethan Grober; Eleftherios P Diamandis; Keith A Jarvi
Journal:  Clin Proteomics       Date:  2012-02-06       Impact factor: 3.988

Review 2.  Immune mediators of chronic pelvic pain syndrome.

Authors:  Stephen F Murphy; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Nat Rev Urol       Date:  2014-04-01       Impact factor: 14.432

3.  CD-163 correlated with symptoms (pain or discomfort) of prostatic inflammation.

Authors:  Fukashi Yamamichi; Katsumi Shigemura; Soichi Arakawa; Kazushi Tanaka; Masato Fujisawa
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 4.  Harnessing the mesenchymal stem cell secretome for regenerative urology.

Authors:  Daniel Z Sun; Benjamin Abelson; Paurush Babbar; Margot S Damaser
Journal:  Nat Rev Urol       Date:  2019-06       Impact factor: 14.432

Review 5.  [Etiology and pathophysiology of benign prostate hyperplasia].

Authors:  A Roosen; C Gratzke; A Herrlemann; G Magistro; F Strittmatter; P Weinhold; S Tritschler; C G Stief
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

6.  Stress response and procedural pain in the preterm newborn: the role of pharmacological and non-pharmacological treatments.

Authors:  Eloisa Gitto; Salvatore Pellegrino; Maria Manfrida; Salvatore Aversa; Giuseppe Trimarchi; Ignazio Barberi; Russel J Reiter
Journal:  Eur J Pediatr       Date:  2011-12-30       Impact factor: 3.183

Review 7.  The functional role of reactive stroma in benign prostatic hyperplasia.

Authors:  Isaiah G Schauer; David R Rowley
Journal:  Differentiation       Date:  2011-06-12       Impact factor: 3.880

8.  Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study.

Authors:  Pradeep Tyagi; Derek Barclay; Ruben Zamora; Naoki Yoshimura; Kenneth Peters; Yoram Vodovotz; Michael Chancellor
Journal:  Int Urol Nephrol       Date:  2009-09-26       Impact factor: 2.370

Review 9.  Chronic pelvic pain syndrome and the overactive bladder: the inflammatory link.

Authors:  Rajiv Saini; Ricardo R Gonzalez; Alexis E Te
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

10.  Associations between quality of life, fatigue, and cytokine levels in patients aged 50+ with acute myeloid leukemia.

Authors:  Abbas H Panju; Ali Danesh; Mark D Minden; David J Kelvin; Shabbir M H Alibhai
Journal:  Support Care Cancer       Date:  2008-10-18       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.